Yoshinori Kobayashi

Yoshinori Kobayashi

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2005 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
YTYasunari Takada
Yasunari Takada
YKYoshinori Kobayashi
Yoshinori Kobayashi
BABharat Aggarwal
Bharat Aggarwal
Evodiamine, an alkaloidal component extracted from the fruit of Evodiae fructus (Evodia rutaecarpa Benth., Rutaceae), exhibits antiproliferative, antimetastatic, and apoptotic activities through a poorly defined mechanism. Because several genes that regulate cellular proliferation, carcinogenesis, metastasis, and survival are regulated by nuclear factor-κB (NF-κB), we postulated that evodiamine mediates its activity by modulating NF-κB activation. In the present study, we investigated the effect of evodiamine on NF-κB and NF-κB-regulated gene expression activated by various carcinogens. We demonstrate that evodiamine was a highly potent inhibitor of NF-κB activation, and it abrogated both inducible and constitutive NF-κB activation. The inhibition corresponded with the sequential suppression of IκBα kinase activity, IκBα phosphorylation, IκBα degradation, p65 phosphorylation, p65 nuclear translocation, and p65 acetylation. Evodiamine also inhibited tumor necrosis factor (TNF)-induced Akt activation and its association with IKK. Suppression of Akt activation was specific, because it had no effect on JNK or p38 MAPK activation. Evodiamine also inhibited the NF-κB-dependent reporter gene expression activated by TNF, TNFR1, TRADD, TRAF2, NIK, and IKK but not that activated by the p65 subunit of NF-κB. NF-κB-regulated gene products such as Cyclin D1, c-Myc, COX-2, MMP-9, ICAM-1, MDR1, Survivin, XIAP, IAP1, IAP2, FLIP, Bcl-2, Bcl-xL, and Bfl-1/A1 were all down-regulated by evodiamine. This down-regulation potentiated the apoptosis induced by cytokines and chemotherapeutic agents and suppressed TNF-induced invasive activity. Overall, our results indicated that evodiamine inhibits both constitutive and induced NF-κB activation and NF-κB-regulated gene expression and that this inhibition may provide a molecular basis for the ability of evodiamine to suppress proliferation, induce apoptosis, and inhibit metastasis.

1 January 2008 in Endocrinology
Verified
Journal Article
Open access
PDF file
TWTing Wang
Ting Wang
YWYouxue Wang
Youxue Wang
YKYasuhide Kontani
Yasuhide Kontani
YKYoshinori Kobayashi
Yoshinori Kobayashi
YSYuzo Sato
Yuzo Sato
HYHitoshi Yamashita
Hitoshi Yamashita
Evodiamine is an alkaloidal compound with antiobesity effects that have been thought to be due to uncoupling protein-1 (UCP1) thermogenesis similar to the effects of capsaicin, but the underlying mechanisms are poorly understood. To clarify the mechanisms, we first examined whether the antiobesity effect of evodiamine could be attributed to the involvement of UCP1. When UCP1-knockout mice were fed a high-fat diet with 0.03% evodiamine (wt/wt) for 2 months, the increases in body weight, adiposity, and the serum levels of leptin and insulin were reduced in a manner indistinguishable from control mice fed a high-fat diet with evodiamine, suggesting that evodiamine triggered a UCP1-independent mechanism to prevent diet-induced obesity. By using preadipocyte cultures, we found that evodiamine, but not capsaicin, increased phosphorylation of ERK/MAPK, reduced the expression of transcription factors such as peroxisome proliferator-activated receptor-γ, and strongly inhibited adipocyte differentiation. Evodiamine treatment also reduced insulin-stimulated phosphorylation of Akt, a crucial regulator of adipocyte differentiation; and the reduction of phosphorylated-Akt and augmentation of phosphorylated ERK were reversed by blockade of the MAPK kinase/MAPK signaling pathway, restoring adipogenesis in the cultures. The changes in ERK and Akt phosphorylation levels were also observed in white adipose tissues of UCP1-knockout mice fed the evodiamine diet. These findings suggest that evodiamine has a potential to prevent the development of diet-induced obesity in part by inhibiting adipocyte differentiation through ERK activation and its negative cross talk with the insulin signaling pathway.

TSTakashi Suzuki
Takashi Suzuki
MMMasahiko Morita
Masahiko Morita
YKYoshinori Kobayashi
Yoshinori Kobayashi
AKAyako Kamimura
Ayako Kamimura
Many human studies report that nitric oxide (NO) improves sport performance. This is because NO is a potential modulator of blood flow, muscle energy metabolism, and mitochondrial respiration durin...

1 May 2003 in Planta Medica
Verified
Journal Article
Closed access
PDF file
YKYoshinori Kobayashi
Yoshinori Kobayashi
Recently, the authors reported that evodiamine, a major alkaloidal principle of Evodia fruits (Evodia rutaecarpa, Rutaceae), had vanilloid receptor agonistic activity comparable to capsaicin. In spite of the similarities in the actions of evodiamine and capsaicin in vitro, the effects of evodiamine on sensory neurons in vivo had not been investigated. We demonstrate here that evodiamine sensitizes and desensitizes the capsaicin-sensitive sensory afferents in mice, resulting in nociceptive action and antinociceptive actions. The nociceptive action (paw licking behaviour) was dose dependently induced by intradermal injection (i. d.) of evodiamine to the hind paw and was suppressed by the co-treatment with capsazepine, a vanilloid receptor specific agonist, in a dose-dependent manner. The treatment with higher dosages of evodiamine showed sustained antinociceptive effects. The acetic acid-induced writhing was significantly suppressed by the intraperitoneal evodiamine administration 3 days before, without any observable effects on spontaneous motor activity. The response of the isolated ileum from the mice with or without high dosages of evodiamine administration indicated the sensory neuron specific desensitizing effect of evodiamine. The isolated ileum from vehicle-treated mice contracted in response to both the sensory nerve stimulation by 10 μM capsaicin and the mimicked vagal stimulation by 2 μM carbachol. However, the isolated ileum from evodiamine-treated mice lost its response to sensory nerve stimuli but retained its response to vagus nerve stimuli. The suppression of acetic acid-induced writhing and the desensitization of visceral sensory neurons strongly correlated [regression coefficient (r) = 0.955]. Thus, we demonstrate that evodiamine shows the analgesic action by desensitizing sensory nerves.

1 October 2005 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
YKYoshinori Kobayashi
Yoshinori Kobayashi
RTRia Takahashi
Ria Takahashi
FOFumiko Ogino
Fumiko Ogino

1 January 1995 in Bioscience, Biotechnology, and Biochemistry
Verified
Journal Article
Closed access
HYHiroaki Yamamoto
Hiroaki Yamamoto
AMAkinobu Matsuyama
Akinobu Matsuyama
YKYoshinori Kobayashi
Yoshinori Kobayashi
NKNaoki Kawada
Naoki Kawada
(S)-1,3-Butanediol (BDO) oxidizing enzyme was purified from Candida parapsilosis IFO 1396, which could produce (R)-1,3-BDO from the racemate. The purified enzyme was an NAD(+)-dependent secondary alcohol dehydrogenase that oxidized (S)-1,3-BDO to 4-hydroxy-2-butanone stereo-specifically.